AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

MYND Life Sciences Inc.

$0.01 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.01
Day Range
$0.01$0.07
Year Range
$0.01$0.07
Market Cap
657.84K
AVG Volume
6.69K
Trailing/Forward PE
-2.18/-
PEG ratio
-0.01
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CAD) · TTM
-60K-40K-20K022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
MYNDF Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
24 Q30
24 Q20
24 Q10
23 Q40
23 Q30
23 Q20
23 Q10
22 Q40
22 Q3-45.94K
22 Q20
Net Income (CAD) · TTM
-6M-4M-2M022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
MYNDF Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
24 Q3-542.57K
24 Q2-694.07K
24 Q1-1.05M
23 Q4-1.52M
23 Q3-2.54M
23 Q2-2.86M
23 Q1-3.1M
22 Q4-3.57M
22 Q3-4.55M
22 Q2-4.57M
Operating Income (CAD) · TTM
-6M-4M-2M022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
MYNDF Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
24 Q3-1.29M
24 Q2-1.26M
24 Q1-1.47M
23 Q4-1.79M
23 Q3-1.4M
23 Q2-1.77M
23 Q1-2.05M
22 Q4-2.55M
22 Q3-4.15M
22 Q2-4.32M
EBITDA (CAD) · TTM
-6M-4M-2M022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
MYNDF EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
24 Q3-1.28M
24 Q2-1.26M
24 Q1-1.45M
23 Q4-1.75M
23 Q3-1.85M
23 Q2-2.21M
23 Q1-2.48M
22 Q4-2.98M
22 Q3-4.07M
22 Q2-4.24M
Cash Flows (CAD) · TTM
-4M-3M-2M-1M01M22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
MYNDF Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
24 Q3-174.08K
24 Q2-223.65K
24 Q1-250.44K
23 Q4-198.26K
23 Q321K
23 Q273.42K
23 Q1-90.25K
22 Q4-1.87M
22 Q3-2.97M
22 Q2-3.83M
EPS (CAD) · TTM
-15-10-5022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
MYNDF EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
24 Q3-0.01
24 Q2-0.01
24 Q1-0.02
23 Q4-0.03
23 Q3-11.72
23 Q2-11.73
23 Q1-11.74
22 Q4-11.75
22 Q3-0.1
22 Q2-0.1
Expenses (CAD) · TTM
-2M02M4M6MR&DSG&ACapex22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
MYNDF Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
24 Q3927.08K
24 Q2920.09K
24 Q11.19M
23 Q41.5M
23 Q31.58M
23 Q21.92M
23 Q12.24M
22 Q42.84M
22 Q33.8M
22 Q24.27M
Shares Outstanding (CAD) · TTM
-750K-500K-250K0250KBuybacks (Repurchases)Stock-Based Compensation22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
MYNDF Shares Outstanding (CAD) · TTM by quarter
PeriodShares Outstanding (CAD) · TTM
24 Q327.12K
24 Q227.12K
24 Q127.12K
23 Q427.12K
23 Q3156.89K
23 Q2207.52K
23 Q1207.52K
22 Q4-103.11K
22 Q3-645.41K
22 Q2-730.42K
Free Cash Flow Yield
-40%-30%-20%-10%0%med -23.97%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MYNDF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-33.7%
Sep 26-33.58%
Aug 26-33.41%
Aug 26-33.74%
Aug 26-33.48%
Aug 26-33.33%
Jul 26-33.15%
Jul 26-32.96%
Jul 26-33.13%
Jul 26-32.82%
Jul 26-32.75%
Jun 26-32.74%
Jun 26-32.85%
Jun 26-33.2%
Jun 26-33.32%
May 26-33.69%
May 26-33.62%
May 26-33.79%
May 26-33.96%
May 26-34.19%
Apr 26-33.99%
Apr 26-33.93%
Apr 26-33.56%
Apr 26-33.37%
Mar 26-33.44%
Mar 26-33.86%
Mar 26-33.85%
Mar 26-34.25%
Feb 26-34.06%
Feb 26-33.97%
Feb 26-34.12%
Feb 26-33.98%
Jan 26-34.11%
Jan 26-33.91%
Jan 26-33.38%
Jan 26-33.39%
Jan 26-33.83%
Dec 25-33.97%
Dec 25-33.66%
Dec 25-33.73%
Dec 25-12.97%
Nov 25-19.51%
Nov 25-19.34%
Nov 25-19.45%
Nov 25-19.41%
Oct 25-19.47%
Oct 25-19.48%
Oct 25-19.45%
Oct 25-19.48%
Oct 25-19.55%
Sep 25-19.56%
Sep 25-19.79%
Sep 25-19.69%
Sep 25-9.29%
Aug 25-9.35%
Aug 25-9.3%
Aug 25-9.3%
Aug 25-9.34%
Aug 25-9.32%
Jul 25-9.38%
Jul 25-9.37%
Jul 25-9.39%
Jul 25-9.46%
Jun 25-9.39%
Jun 25-9.36%
Jun 25-9.46%
Jun 25-9.39%
May 25-9.35%
May 25-9.36%
May 25-26.94%
May 25-27.01%
May 25-27.24%
Apr 25-27.17%
Apr 25-27.2%
Apr 25-27.14%
Apr 25-26.45%
Mar 25-26.29%
Mar 25-4.28%
Mar 25-20.95%
Mar 25-20.96%
Feb 25-20.82%
Feb 25-21.17%
Feb 25-21.23%
Feb 25-21.07%
Jan 25-20.72%
Jan 25-4.61%
Jan 25-20.79%
Jan 25-20.88%
Jan 25-20.84%
Dec 24-4.59%
Dec 24-4.6%
Dec 24-4.65%
Dec 24-4.67%
Nov 24-4.72%
Nov 24-3.99%
Nov 24-21.37%
Nov 24-21.65%
Nov 24-21.58%
Oct 24-27.84%
Oct 24-28.02%
Price to Sales
-200-150-100-500med -24.73Nov 22Nov 22Dec 22Dec 22Dec 22Jan 23Jan 23
MYNDF Price to Sales by quarter
PeriodPrice to Sales
Jan 23-24.22
Jan 23-24.35
Jan 23-24.38
Jan 23-24.47
Dec 22-24.65
Dec 22-24.73
Dec 22-24.93
Dec 22-24.83
Dec 22-24.52
Nov 22-64.11
Nov 22-94.75
Nov 22-95.74
Nov 22-190.83
Price/Operating Cashflow
020406080100med 74.99Aug 23Dec 23Jan 24Jan 24
MYNDF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Jan 2460.24
Jan 2490.21
Jan 2490.07
Jan 2489.75
Dec 2392.56
Aug 2314.66
Aug 2314.6
Aug 2314.49
Price to Book
050100150200med 34.82Sep 21Oct 21Nov 21Nov 21Dec 21Jan 22Jan 22
MYNDF Price to Book by quarter
PeriodPrice to Book
Jan 2224.06
Jan 2227.02
Jan 2226.97
Jan 2230.98
Dec 2126.33
Dec 2126.66
Dec 2127.39
Dec 2125.09
Dec 2136.48
Nov 2150.76
Nov 2164.79
Nov 21112.94
Nov 2193.63
Oct 21166.81
Oct 2151.68
Oct 2134.09
Oct 2134.82
Oct 2135.31
Sep 2135.32
MYND Life Sciences Inc.
MYNDF
Stockpicker

Video analysis: MYNDF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.